<table border="1" cellpadding="0" cellspacing="0" width="612" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<tbody>
<tr>
<td>
<content stylecode="bold">Regimen </content>
</td>
<td>
<content stylecode="bold">Cmax (mcg/mL) </content>
</td>
<td>
<content stylecode="bold">Tmax (h) </content>
</td>
<td>
<content stylecode="bold">AUC (mcg</content>•<content stylecode="bold">h/mL) </content>
</td>
<td>
<content stylecode="bold">CL/F</content>
<sup>1</sup>
<content stylecode="bold">(mL/min) </content>
</td>
<td>
<content stylecode="bold">Vd/F</content>
<sup>2</sup>
<content stylecode="bold">(L) </content>
</td>
<td>
<content stylecode="bold">t<sub>1/2</sub> (h) </content>
</td>
<td>
<content stylecode="bold">CL<sub>R</sub> (mL/min) </content>
</td>
</tr>
<tr>
<td>
<content stylecode="bold">Single dose </content>
</td>
<td> </td>
</tr>
<tr>
<td>250 mg oral tablet<sup>3</sup>
</td>
<td>2.8 ± 0.4 </td>
<td>1.6 ± 1 </td>
<td>27.2 ± 3.9 </td>
<td>156 ± 20 </td>
<td>ND </td>
<td>7.3 ± 0.9 </td>
<td>142 ± 21 </td>
</tr>
<tr>
<td>500 mg oral tablet<sup>3*</sup>
</td>
<td>5.1 ± 0.8 </td>
<td>1.3 ± 0.6 </td>
<td>47.9 ± 6.8 </td>
<td>178 ± 28 </td>
<td>ND </td>
<td>6.3 ± 0.6 </td>
<td>103 ± 30 </td>
</tr>
<tr>
<td>750 mg oral tablet<sup>5*</sup>
</td>
<td>9.3 ± 1.6 </td>
<td>1.6 ± 0.8 </td>
<td>101 ± 20 </td>
<td>129 ± 24 </td>
<td>83 ± 17 </td>
<td>7.5 ± 0.9 </td>
<td>ND </td>
</tr>
<tr>
<td>
<content stylecode="bold">Multiple dose </content>
</td>
<td> </td>
</tr>
<tr>
<td>500 mg every 24h oral tablet<sup>3 </sup>
</td>
<td>5.7 ± 1.4 </td>
<td>1.1 ± 0.4 </td>
<td>47.5 ± 6.7 </td>
<td>175 ± 25 </td>
<td>102 ± 22 </td>
<td>7.6 ± 1.6 </td>
<td>116 ± 31 </td>
</tr>
<tr>
<td>750 mg every 24h oral tablet<sup>5 </sup>
</td>
<td>8.6 ± 1.9 </td>
<td>1.4 ± 0.5 </td>
<td>90.7 ± 17.6 </td>
<td>143 ± 29 </td>
<td>100 ± 16 </td>
<td>8.8 ± 1.5 </td>
<td>116 ± 28 </td>
</tr>
<tr>
<td>
<content stylecode="bold">500 mg oral tablet single dose, effects of gender and age: </content>
</td>
<td> </td>
</tr>
<tr>
<td>Male<sup>8</sup>
</td>
<td>5.5 ± 1.1 </td>
<td>1.2 ± 0.4 </td>
<td>54.4 ± 18.9 </td>
<td>166 ± 44 </td>
<td>89 ± 13 </td>
<td>7.5 ± 2.1 </td>
<td>126 ± 38 </td>
</tr>
<tr>
<td>Female<sup>9 </sup>
</td>
<td>7.0 ± 1.6 </td>
<td>1.7 ± 0.5 </td>
<td>67.7 ± 24.2 </td>
<td>136 ± 44 </td>
<td>62 ± 16 </td>
<td>6.1 ± 0.8 </td>
<td>106 ± 40 </td>
</tr>
<tr>
<td>Young<sup>10 </sup>
</td>
<td>5.5 ± 1</td>
<td>1.5 ± 0.6 </td>
<td>47.5 ± 9.8 </td>
<td>182 ± 35 </td>
<td>83 ± 18 </td>
<td>6.0 ± 0.9 </td>
<td>140 ± 33 </td>
</tr>
<tr>
<td>Elderly<sup>11 </sup>
</td>
<td>7.0 ± 1.6 </td>
<td>1.4 ± 0.5 </td>
<td>74.7 ± 23.3 </td>
<td>121 ± 33 </td>
<td>67 ± 19 </td>
<td>7.6 ± 2 </td>
<td>91 ± 29 </td>
</tr>
<tr>
<td>
<content stylecode="bold">500 mg oral single dose tablet, patients with renal insufficiency: </content>
</td>
<td> </td>
</tr>
<tr>
<td>CLCR 50 to 80 mL/min </td>
<td>7.5 ± 1.8 </td>
<td>1.5 ± 0.5 </td>
<td>95.6 ± 11.8 </td>
<td>88 ± 10 </td>
<td>ND </td>
<td>9.1 ± 0.9 </td>
<td>57 ± 8 </td>
</tr>
<tr>
<td>CLCR 20 to 49 mL/min </td>
<td>7.1 ± 3.1 </td>
<td>2.1 ± 1.3 </td>
<td>182.1 ± 62.6 </td>
<td>51 ± 19 </td>
<td>ND </td>
<td>27 ± 10 </td>
<td>26 ± 13 </td>
</tr>
<tr>
<td>CLCR &lt;20 mL/min </td>
<td>8.2 ± 2.6 </td>
<td>1.1 ± 1 </td>
<td>263.5 ± 72.5 </td>
<td>33 ± 8 </td>
<td>ND </td>
<td>35 ± 5 </td>
<td>13 ± 3 </td>
</tr>
<tr>
<td>Hemodialysis </td>
<td>5.7 ± 1 </td>
<td>2.8 ± 2.2 </td>
<td>ND </td>
<td>ND </td>
<td>ND </td>
<td>76 ± 42 </td>
<td>ND </td>
</tr>
<tr>
<td>CAPD </td>
<td>6.9 ± 2.3 </td>
<td>1.4 ± 1.1 </td>
<td>ND </td>
<td>ND </td>
<td>ND </td>
<td>51 ± 24 </td>
<td>ND </td>
</tr>
</tbody>
</table>